Co-Diagnostics Inc
CODX
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.35M
Close$
$7.86
910.3% upside
Current Fair Value
910.3% upsideUndervalued by 910.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.35 Million |
|---|---|
| Enterprise Value | $1.53 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-35.25 |
| Beta | 2.9 |
| Outstanding Shares | 4,309,997 |
Return
| Return on Equity | -370.16% |
|---|---|
| Return on Assets | -283.63% |
| Return on Invested Capital | -343.85% |
Valuation & Multiples
| P/E Ratio | -0.04 |
|---|---|
| PEG | 0.22 |
| Price to Sales | - |
| Price to Book Ratio | 0.26 |
| Enterprise Value to Revenue | 2.12 |
| Enterprise Value to EBIT | -0.03 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.19 |
| Debt to Equity | 0.14 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 14, 2026
EPS Estimate
$-3.00
Average shareholder expectationRevenue Estimate
$132,576
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-2.85
Average shareholder expectationRevenue Estimate
$143,624
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 13.82%▲ 11.64% |
|---|---|
| Total Invested | $1.85M▲ 1918.98% |
| Investors Holding | 24▲ 10.00% |
ESG Score
No data
About Co-Diagnostics Inc
CEO: Dwight Egan